Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- London
- Most recent report
- 8-K, filed Jan 16, 2025
- Filings on record
- 233 filings
- On EDGAR
- CIK 1811115
- Fiscal year ends
- June
- Filer status
- Emerging growth company
Financials 8 of 47
- 10-Q Quarterly report Nov 19, 2024
- 10-K Annual report Sep 30, 2024
- 10-Q Quarterly report May 15, 2024
- 10-Q Quarterly report Feb 14, 2024
- 10-Q Quarterly report Nov 14, 2023
- 10-K/A Annual report, amended Oct 6, 2023
- 10-K Annual report Sep 28, 2023
- 6-K Report a foreign issuer made public elsewhere Jun 30, 2023
News 8 of 45
- 8-K Current report on a material event Jan 16, 2025
- 8-K Shareholder vote results Dec 20, 2024
- 8-K/A Significant contract Nov 19, 2024
- 8-K Leadership change Nov 6, 2024
- 8-K Quarterly results Oct 1, 2024
- 8-K Current report on a material event Aug 27, 2024
- 8-K Current report on a material event Jul 15, 2024
- 8-K/A Current report on a material event, amended Jun 25, 2024
Prospectuses and Registrations 8 of 31
- 424B3 Prospectus supplement for an offering Jul 30, 2025
- POS AM Post-effective amendment to a registration Jul 29, 2025
- POS AM Post-effective amendment to a registration Jul 29, 2025
- POS AM Post-effective amendment to a registration Jul 29, 2025
- POS AM Post-effective amendment to a registration Jul 29, 2025
- POS AM Post-effective amendment to a registration Jul 29, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jul 25, 2025
- S-8 POS Post-effective amendment to an employee plan registration Jul 25, 2025
Proxies 8 of 10
- DEF 14A Proxy statement for a shareholder vote Nov 25, 2024
- PRE 14A Preliminary proxy statement Nov 12, 2024
- DEF 14A Proxy statement for a shareholder vote Oct 11, 2024
- PRE 14A Preliminary proxy statement Oct 1, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 29, 2024
- PRE 14A Preliminary proxy statement Mar 19, 2024
- DEFA14A Extra proxy material Dec 8, 2023
- DEFR14A Nov 13, 2023
Ownership 8 of 47
- SCHEDULE 13D/A Large holder reported an active stake, amended Feb 23, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 30, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Apr 30, 2025
- SCHEDULE 13G Large holder reported a passive stake Feb 10, 2025
- SC 13G/A Large holder reported a passive stake, amended Nov 14, 2024
- SC 13D/A Large holder reported an active stake, amended Nov 7, 2024
- 4 Insider reported a trade Nov 5, 2024
- SC 13D/A Large holder reported an active stake, amended Nov 5, 2024
Other 8 of 53
- F-6 POS Dec 3, 2025
- F-6 POS Sep 4, 2025
- EFFECT Notice that a registration became effective Jul 30, 2025
- EFFECT Notice that a registration became effective Jul 30, 2025
- EFFECT Notice that a registration became effective Jul 30, 2025
- EFFECT Notice that a registration became effective Jul 30, 2025
- EFFECT Notice that a registration became effective Jul 30, 2025
- 15-12G Jul 30, 2025
Everything here comes from Renalytix plc's own filings on SEC EDGAR. The filing list is rechecked every hour.